BU-NOT-SET

CONTACT US
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
  • Drug product
Two lab workers
Case study
Recipharm Wins two 2020 CMO Leadership Awards
  • Industry trends
Eyes
Insight
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
White paper
  • Biologics
  • Manufacturing
Advanced Bio is advancing rAAV production
White paper
  • Biologics
  • Manufacturing
Advanced Bio Is advancing LNP formulation
White paper
  • Drug product
  • Manufacturing
Optimising drug formulation: The critical role of granulation
Case study
  • Drug product
  • Manufacturing
Overcoming fixed-dose combination challenges for ALS
Video
  • Industry trends
What’s shaping the future of pharma?
Insight
  • Drug product
  • Manufacturing
Mastering tech-transfer: Turning complexity into competitive advantage
Insight
  • Drug product
  • Manufacturing
Four ways ReciPredict can transform your pharma manufacturing
Insight
  • Analytical chemistry
  • Industry trends
An expert’s guide to analytical services
Insight
  • Drug product
  • Manufacturing
How lyophilisation can help overcome mRNA stability challenges